Canada - Tiếng Anh - Health Canada

sterimax inc - ceftriaxone (ceftriaxone sodium) - powder for solution - 1g - ceftriaxone (ceftriaxone sodium) 1g - third generation cephalosporins

Canada - Tiếng Anh - Health Canada

sterimax inc - ceftriaxone (ceftriaxone sodium) - powder for solution - 2g - ceftriaxone (ceftriaxone sodium) 2g - third generation cephalosporins

Canada - Tiếng Anh - Health Canada

sterimax inc - ceftriaxone (ceftriaxone sodium) - powder for solution - 10g - ceftriaxone (ceftriaxone sodium) 10g - third generation cephalosporins

Canada - Tiếng Anh - Health Canada

pfizer canada ulc - ceftriaxone (ceftriaxone sodium) - powder for solution - 2g - ceftriaxone (ceftriaxone sodium) 2g - third generation cephalosporins

Canada - Tiếng Anh - Health Canada

fresenius kabi canada ltd - ceftriaxone (ceftriaxone sodium) - powder for solution - 250mg - ceftriaxone (ceftriaxone sodium) 250mg - third generation cephalosporins

Canada - Tiếng Anh - Health Canada

fresenius kabi canada ltd - ceftriaxone (ceftriaxone sodium) - powder for solution - 1g - ceftriaxone (ceftriaxone sodium) 1g - third generation cephalosporins

Canada - Tiếng Anh - Health Canada

fresenius kabi canada ltd - ceftriaxone (ceftriaxone sodium) - powder for solution - 2g - ceftriaxone (ceftriaxone sodium) 2g - third generation cephalosporins

Canada - Tiếng Anh - Health Canada

fresenius kabi canada ltd - ceftriaxone (ceftriaxone sodium) - powder for solution - 10g - ceftriaxone (ceftriaxone sodium) 10g - third generation cephalosporins

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

auromedics pharma llc - oxacillin sodium (unii: g0v6c994q5) (oxacillin - unii:uh95vd7v76) - oxacillin 2 g - oxacillin is indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organism and its susceptibility to the drug. (see clinical pharmacology - susceptibility test methods .) oxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of susceptibility test results. oxacillin should not be used in infections caused by organisms susceptible to penicillin g. if the susceptibility tests indicate that the infection is due to an organism other than a resistant staphylococcus , therapy should not be continued with oxacillin. to reduce the development of drug-resistant bacteria and maintain the effectiveness of oxacillin for injection, usp and other antibacterial drugs, oxacillin for injection, usp should be used only to treat or prevent infections that are proven or str

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

auromedics pharma llc - oxacillin sodium (unii: g0v6c994q5) (oxacillin - unii:uh95vd7v76) - oxacillin 10 g in 100 ml - oxacillin is indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organism and its susceptibility to the drug. (see clinical pharmacology - susceptibility test methods .) oxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of susceptibility test results. oxacillin should not be used in infections caused by organisms susceptible to penicillin g. if the susceptibility tests indicate that the infection is due to an organism other than a resistant staphylococcus , therapy should not be continued with oxacillin. to reduce the development of drug-resistant bacteria and maintain the effectiveness of oxacillin for injection, usp and other antibacterial drugs, oxacillin for injection, usp should be used only to treat or prevent infections that are proven or stro